| 2002 |
KREMEN1 and KREMEN2 are high-affinity DKK1 receptors that functionally cooperate with DKK1 to block Wnt/β-catenin signaling. KREMEN2 forms a ternary complex with DKK1 and LRP6, inducing rapid endocytosis and removal of the Wnt co-receptor LRP6 from the plasma membrane. |
Co-immunoprecipitation, endocytosis assays, Xenopus embryo overexpression/rescue experiments, binding assays |
Nature |
High |
12050670
|
| 2002 |
Kremen1 and Kremen2 functionally interact with Dkk1 to regulate anteroposterior CNS patterning in Xenopus. Morpholino knockdown of Krm1/2 leads to anterior neural defects, and Krm2 synergizes with Dkk1 in inhibiting Wnt/LRP6 signaling in axis duplication assays. |
Antisense morpholino knockdown, axis duplication assays, antibody rescue experiments, Xenopus embryology |
Development (Cambridge, England) |
High |
12421700
|
| 2007 |
Kremen2 functions independently of Dkks during neural crest induction in Xenopus: Krm2 binds LRP6, promotes its cell-surface localization, and stimulates LRP6-mediated Wnt/β-catenin signaling. Morpholino-mediated Krm2 knockdown reduces LRP6 protein levels in neural crest explants and inhibits neural crest induction. |
Morpholino knockdown, overexpression, cell-surface localization assays, LRP6 protein quantification in explants |
Development (Cambridge, England) |
High |
17978005
|
| 2008 |
DKK1 residues Arg197, Ser198, and Lys232 are specifically required for DKK1 binding to Kremen (but not LRP6), localized on the opposite surface from the LRP6-binding site. DKK1 mutants at these Kremen-binding residues retain Wnt antagonism unless both LRP6 and Kremen are co-expressed, suggesting Kremen is not essential for DKK1-mediated Wnt antagonism except when LRP5/6 is highly expressed. |
Site-directed mutagenesis, binding assays, Wnt signaling reporter assays, 3D structural modeling based on DKK2 structure |
The Journal of biological chemistry |
High |
18502762
|
| 2006 |
Kremen1 knockout in mice causes severe defects in thymic cortical architecture including large epithelial-free regions and failure of epithelial maturation, with a 2-fold increase in canonical Wnt signaling in TEC lines derived from krm1−/− mice compared to wild-type. |
Knockout mouse analysis, TOPFlash Wnt reporter assay, FACS, immunostaining |
Clinical & developmental immunology |
Medium |
17162372
|
| 2015 |
Kremen1 acts as a dependence receptor, triggering cell death (apoptosis) in the absence of its ligand DKK1 through a Wnt-independent mechanism. A specific motif in the cytoplasmic tail of Kremen1, conserved only in placental mammals, is strictly required for apoptosis induction. Pro-apoptotic and anti-Wnt functions are separable by mutagenesis. |
Whole embryo culture, Wnt-activity reporter assays, mutagenesis of cytoplasmic tail, phylogenetic analysis, loss-of-function experiments |
Cell death and differentiation |
High |
26206087
|
| 2016 |
Crystal structures of the human KREMEN1 ectodomain (KRM1ECD) at 1.9–3.2 Å reveal a rigid molecule with a triangular arrangement of Kringle, WSC, and CUB domains. A low-resolution ternary complex crystal structure with LRP6 PE3PE4 and DKK1 CRD2 shows DKK1 CRD2 sandwiched between LRP6 PE3 and KRM1 Kringle-WSC, with surface plasmon resonance suggesting a direct interaction between KRM1 CUB and LRP6 PE2. |
X-ray crystallography (multiple structures), surface plasmon resonance, structural modeling |
Structure (London, England : 1993) |
High |
27524201
|
| 2018 |
KREMEN1 is an entry receptor for Coxsackievirus A10 (CV-A10) and a related phylogenetic group of EV-A enteroviruses. Loss of KREMEN1 renders cells resistant to CV-A10 infection; KREMEN1 overexpression enhances CV-A10 binding and susceptibility; the KREMEN1 extracellular domain neutralizes infection. Kremen-deficient mice are resistant to CV-A10-induced lethal paralysis. |
Haploid genetic screen, CRISPR/loss-of-function, overexpression, soluble ectodomain neutralization assay, Kremen-knockout mouse infection model |
Cell host & microbe |
High |
29681460
|
| 2020 |
Crystal structures of CV-A10 alone, in complex with KRM1, and of the CV-A10 A-particle reveal that KRM1 spans the viral canyon with a large footprint, and that KRM1 binding induces release of a pocket factor and produces expanded (uncoating-primed) viral particles, identifying KRM1 as a two-in-one attachment and uncoating receptor. |
Cryo-EM and X-ray crystallography, in vitro uncoating assay at acidic pH |
Nature communications |
High |
31911601 32690697
|
| 2012 |
KREMEN1 is internalized from the cell surface by clathrin-mediated endocytosis via an atypical dileucine motif (DXXXLV) in its cytoplasmic tail. Mutation of LV to AA in this motif blocks internalization. AP-2 knockdown or clathrin inhibition with pitstop 2 also blocks KREMEN1 internalization. |
Site-directed mutagenesis of endocytic motif, siRNA knockdown of AP-2, pharmacological clathrin inhibition, cell-surface internalization assays |
PloS one |
Medium |
23251700
|
| 2019 |
Kremen1 apoptotic signaling requires homodimerization; forced dimerization increases apoptotic signaling while DKK1 binding inhibits Kremen1 multimerization and alleviates cell death. Kremen2 (which has no intrinsic apoptotic activity) binds Kremen1 and acts as a potent inhibitor of Kremen1-induced cell death through heterodimerization. |
Dimerization assays, forced dimerization constructs, co-immunoprecipitation of Kremen1/Kremen2 heterodimers, cell death assays |
Cell death discovery |
Medium |
31069116
|
| 2016 |
Kremen1 is expressed in prosensory cells during cochlear development and in supporting cells of the adult mouse cochlea. Gain- and loss-of-function experiments show Kremen1 is sufficient to bias cells towards supporting cell fate and suppresses hair cell formation. Loss of Kremen1 in zebrafish results in more hair cells per neuromast. |
Gain-of-function overexpression, loss-of-function (genetic/MO), immunolocalization, hair cell counting in mouse cochlea and zebrafish lateral line |
Scientific reports |
Medium |
27550540
|
| 2014 |
In the zebrafish posterior lateral line primordium, Kremen1 loss causes decreased (rather than increased) Wnt signaling phenotypes in a non-cell-autonomous manner. Ectopic Dkk1b-mTangerine shows larger spread in krm1 mutant primordia, indicating that Kremen1 restricts the diffusion range of secreted Dkk proteins, modulating Wnt activity by limiting Dkk spread rather than solely facilitating LRP6 endocytosis. |
Zebrafish kremen1 mutant analysis, transplantation rescue assay (non-cell-autonomy test), fluorescent Dkk1b fusion protein imaging |
Development (Cambridge, England) |
Medium |
25038040
|
| 2021 |
KREMEN1 is sufficient to mediate SARS-CoV-2 (but not SARS-CoV) entry into cells independently of ACE2. KREMEN1 binds the SARS-CoV-2 spike protein and supports viral entry in vitro and in vivo. SARS-CoV-2 uses distinct ACE2/ASGR1/KREMEN1 receptor combinations depending on cell type. |
Genome-wide receptor screen (5054 membrane proteins), viral entry assays (in vitro and in vivo), neutralizing antibody blockade, human lung organoid infection |
Cell research |
High |
34837059
|
| 2020 |
DKK3 co-localizes with Kremen-1 in microglia following intracerebral hemorrhage. In vivo Kremen-1 siRNA knockdown attenuates the protective effects of exogenous DKK3 on brain edema and neuroinflammation, placing Kremen-1 downstream of DKK3 in a pathway suppressing JNK/AP-1-mediated neuroinflammation. |
siRNA knockdown in vivo, Western blot, immunofluorescence co-localization, behavioral neuroscience readouts |
Journal of neuroinflammation |
Medium |
32331523
|
| 2018 |
DKK4 CRD2 mediates high-affinity binding to both LRP6 E1E2 and the Kremen1 extracellular domain. DKK4 and Kremen1 function synergistically to inhibit Wnt signaling. The N-terminal region (CRD1) does not interact with Kremen proteins. |
Surface plasmon resonance, NMR structural analysis, Wnt reporter assay (synergy), domain-deletion binding experiments |
The Journal of biological chemistry |
Medium |
29925589
|
| 2016 |
Homozygous KREMEN1 p.F209S variant (in the extracellular WSC domain) causes autosomal recessive ectodermal dysplasia with oligodontia in Palestinian families, demonstrating that Kremen1 WSC domain function is required for normal ectodermal/dental development in humans. |
Exome sequencing, Sanger genotyping in 56 relatives, variant localization to WSC domain |
European journal of human genetics : EJHG |
Medium |
27049303
|
| 2025 |
Disease-associated KREMEN1 variants (Cys111Ser, Gly166Asp, Phe209Ser, Phe258_Pro259del) show reduced N- and O-glycosylation compared to wild type. These variants have reduced ability to form ternary complexes with DKK1 and LRP6 (though KREMEN1-LRP6 binary interaction is not impaired by missense variants). Patient fibroblasts show higher basal WNT activity and attenuated response to WNT3A stimulation. |
Ectopic expression in HEK293T cells, glycosylation analysis, co-immunoprecipitation of ternary and binary complexes, WNT pathway reporter assays in patient fibroblasts |
The Journal of investigative dermatology |
Medium |
40553753
|
| 2026 |
Kremen1 induces cell death with autophagic (rather than apoptotic) features when unbound by DKK1. Proximity labeling identified SEC24C (COP-II complex component) as a critical effector. Kremen1 is in proximity with SEC24C and ATG9A after vesicular trafficking; this fosters proximity of SEC24C with ATG8, ERGIC, and ATG9A, increasing autophagosomes and leading to cell death. |
Pharmacological inhibition of autophagy, genetic silencing of autophagy effectors, biotin proximity labeling (BioID/TurboID) for protein-protein interactions, functional cell death assays |
Cell communication and signaling : CCS |
Medium |
41807954
|
| 2025 |
VP2 residue K140 (K2140) is completely conserved in all KRM1-dependent enteroviruses and is essential for KRM1 receptor recognition and infection by CVA2-CVA6, CVA10, CVA12, and CVA8. KRM1 residue D90 engages directly with K2140 to mediate receptor binding. |
Mutational analysis, viral binding and infection assays, in vivo mouse pathogenicity, receptor-identification assay for CVA8 |
mBio |
Medium |
39817751
|
| 2008 |
DKK1 and Kremen1 are co-expressed and dynamically regulated in embryos and uterine stroma during the window of implantation. Antisense oligonucleotide knockdown of Kremen1 inhibits blastocyst adhesion and outgrowth on fibronectin in vitro, and DKK1 antisense injection into mouse uterine horns inhibits embryo implantation in vivo. |
Immunofluorescence/immunohistochemistry for co-expression, antisense ODN knockdown in vitro and in vivo, blastocyst adhesion assay |
Fertility and sterility |
Medium |
18068158
|
| 2018 |
Silencing Kremen1 with miR-431 prevents amyloid-β-mediated synapse loss (reduction in pre- and post-synaptic puncta) and neurite degeneration in cortico-hippocampal cultures from 3xTg-AD mice, demonstrating a required role for Kremen1 in DKK1/Aβ-induced synaptic degeneration. |
miRNA transfection (miR-431) targeting Kremen1, synaptic puncta quantification, neurite degeneration assay in primary neuronal cultures |
Frontiers in cellular neuroscience |
Low |
29643768
|
| 2001 |
KREMEN (KREMEN1) is a type-I transmembrane protein with a kringle domain, a WSC domain, and CUB domains in the extracellular region and no conserved signaling motif in its intracellular region. Its mRNA increases during embryonic development and during differentiation of C2C12 and NIE-115 cells into muscle and neural cells respectively. |
Kringle-SAGE cloning strategy, sequence/domain analysis, Northern blot expression analysis, in situ hybridization in mouse embryos |
Biochimica et biophysica acta |
Medium |
11267660
|